By condition and life stage
GLP-1 and Birth Control: What Women Need to Know
Medically reviewed by Editorial Medical Review, MD, NAMS-CMP · Updated July 2026
Quick answer
The tirzepatide label warns that Zepbound and Mounjaro may reduce the effectiveness of oral birth control and advises a non-oral or backup barrier method for 4 weeks after starting and after each dose increase. The semaglutide label carries no such warning. For women on the pill, this is a key difference between the two drug classes.
The tirzepatide oral-contraceptive warning
Tirzepatide slows stomach emptying, which can affect how oral medications, including birth-control pills, are absorbed. The FDA labels for Zepbound and Mounjaro therefore advise switching to a non-oral contraceptive method, or adding a barrier method, for 4 weeks after starting tirzepatide and for 4 weeks after each dose increase.
This is a specific, label-based instruction. It does not mean the pill stops working entirely, but it does mean relying on it alone during those windows may not be reliable.
Semaglutide does not carry this warning
The semaglutide labels (Wegovy, Ozempic, Rybelsus) do not include the oral-contraceptive warning that tirzepatide does. If reliable oral contraception is a priority, that difference is worth raising with a clinician when choosing between the two drug classes.
Separately, weight loss itself can restore ovulation, so effective contraception still matters on either drug if pregnancy is not intended.
Practical options and pregnancy cautions
Non-oral methods such as an IUD, implant, injection, patch, or ring are not absorbed through the stomach, so they are not affected by the tirzepatide absorption concern. A barrier method used consistently is the label-suggested add-on for oral-pill users during the relevant windows.
All GLP-1 labels advise against use in pregnancy and stopping before a planned pregnancy, which is a different topic from contraception but part of the same planning conversation. This is contraception guidance, not the HRT question, which our dedicated Q&A covers separately.
Key points
- Tirzepatide (Zepbound, Mounjaro) may reduce oral birth-control effectiveness.
- Use a non-oral or backup barrier method for 4 weeks after starting and after each dose increase.
- Semaglutide (Wegovy, Ozempic, Rybelsus) carries no oral-contraceptive warning.
- Weight loss can restore ovulation, so contraception matters on either drug.
Molecule facts (canonical explainers)
This is a decision guide. For the plain-fact explainer of each molecule (mechanism, FDA status, dosing cautions), see:
- Zepbound for women — GIP/GLP-1 receptor dual agonist (tirzepatide)
- Wegovy for women — GLP-1 receptor agonist (semaglutide 2.4 mg)
Providers we review in this area
Editorial reviews only — not treatment recommendations. Prescribing decisions rest with a licensed clinician. For the full directory, see all GLP-1 for women providers.
- Pandia Health — Women-led birth control and women's health telehealth that includes PCOS-relevant care (hormonal birth control, spironolactone, metformin where appropriate).
- Form Health — Board-certified obesity medicine physicians prescribing GLP-1s. Often insurance-covered — among the most affordable options when insurance applies.
- Plushcare GLP-1 — Primary care telehealth that prescribes Wegovy and Zepbound when clinically appropriate. Insurance-friendly.
Cost
Contraception guidance does not change GLP-1 pricing; cost tracks the chosen drug. See the insurance-coverage guide for coverage details.
See the full cost breakdown in our Does insurance cover GLP-1 drugs?.
Related questions
Frequently asked questions
- Does tirzepatide make birth control pills less effective?
- The tirzepatide label warns it may reduce oral-contraceptive effectiveness and advises a non-oral or added barrier method for 4 weeks after starting and after each dose increase. It does not eliminate the pill effect, but the label recommends backup during those windows.
- Is semaglutide safe with birth control pills?
- The semaglutide labels do not carry the oral-contraceptive warning that tirzepatide does. However, weight loss itself can restore ovulation, so reliable contraception still matters if pregnancy is not intended.
- Which birth control is not affected by a GLP-1?
- Non-oral methods such as an IUD, implant, injection, patch, or ring are not absorbed through the stomach, so they are not affected by the tirzepatide absorption concern. Discuss the best option for you with a clinician.
Sources
Every efficacy, safety, and price claim above resolves to an FDA label, published trial, guideline, or manufacturer / GoodRx pricing page. External links open in a new tab.
- FDA Mounjaro Prescribing Information (tirzepatide), NDA 215866 ↗
- FDA Zepbound (tirzepatide) approval record, Drugs@FDA NDA 217806 ↗
- FDA Wegovy Prescribing Information (semaglutide 2.4 mg), NDA 215256 ↗
- FDA Ozempic Prescribing Information (semaglutide), NDA 209637 ↗
- FDA Rybelsus Prescribing Information (oral semaglutide), NDA 213051 ↗
Keep reading
ClearHormones updates these guides as FDA status and pricing change. Verify current approval status and pricing on the manufacturer or FDA page before acting.